Pediatrix Medical (MD) Receivables (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Receivables data on file, last reported at $224.8 million in Q1 2026.

• Quarterly Receivables fell 7.31% year-over-year to $224.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $224.8 million (down 7.31% YoY) and the FY2025 annual result came in at $229.7 million, down 20.39% from the prior year.
• Receivables eased to $224.8 million in Q1 2026 per MD's latest filing, from $229.7 million in the prior quarter.
• Across five years, Receivables topped out at $1.6 billion in Q4 2022 and bottomed at $224.8 million in Q1 2026.
• The 5-year median for Receivables is $283.7 million (2024), against an average of $761.0 million.
• The widest annual swing landed in 2022, when Receivables soared 500.93%; it then tumbled 84.27% in 2025.
• Tracing MD's Receivables over 5 years: stood at $1.6 billion in 2022, then slipped by 11.9% to $1.4 billion in 2023, then plunged by 79.57% to $288.5 million in 2024, then retreated by 20.39% to $229.7 million in 2025, then retreated by 2.12% to $224.8 million in 2026.
• Per Business Quant, the three latest MD Receivables figures stand at $224.8 million (Q1 2026), $229.7 million (Q4 2025), and $231.1 million (Q3 2025).

Peer Comparison